Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Accounts Payables: 2023-2024

Historic Accounts Payables for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $6.5 million.

  • CG Oncology's Accounts Payables fell 18.85% to $9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.2 million, marking a year-over-year decrease of 18.85%. This contributed to the annual value of $6.5 million for FY2024, which is 101.02% up from last year.
  • Latest data reveals that CG Oncology reported Accounts Payables of $6.5 million as of FY2024, which was up 101.02% from $3.2 million recorded in FY2023.
  • In the past 5 years, CG Oncology's Accounts Payables registered a high of $6.5 million during FY2024, and its lowest value of $3.2 million during FY2023.
  • For the 2-year period, CG Oncology's Accounts Payables averaged around $4.9 million, with its median value being $4.9 million (2023).
  • Data for CG Oncology's Accounts Payables shows a peak YoY spiked of 101.02% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows CG Oncology's Accounts Payables stood at $3.2 million in 2023, then surged by 101.02% to $6.5 million in 2024.